Biotrial is an independent European CRO, offering a full range of services to the biotech and pharma industries: phase I studies in healthy volunteers & specific populations, phase II-IV trial management, data management, biostatistics, ECG and imaging central lab, medical writing & non clinical pharmacology. With over 80 phase I studies/year, 150 beds in 3 different phase I units, Biotrial, leading service provider in early development in Europe, has a specific approach for biotech & start up companies, and performs global studies from Non Clinical to Phase IV. Areas of expertise include first administration in man and clinical pharmacology, in the fields of CNS, CV, immunology, inflammation, infectious diseases, hematology, endocrinology, metabolism and ophtalmology. Biotrial has also established a strong specific group for oncology services with links to anticancer institutes and oncology departments throughout Europe, performing trial from early development up to phase III.
| Legal Name |
BIOTRIAL |
| Director Name |
GANDON Jean-Marc |
| French Legal Category |
Simplified Share Holding Company |
| Registered capital (in Euros) |
3 006 300 |
| Year company founded |
2/27/2004 |
| Etablishment legal status |
Simplified Share Holding Company |
| % Turnover from export |
unknown |
| Related activities |
|
|